Douglas Lane & Associates, LLC Zoetis Inc. Transaction History

Douglas Lane & Associates, LLC

$7.1 Billion
Q3 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 8,281 shares of ZTS stock, worth $1.45 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,281

Previous 8,175 1.3%

Holding current value

$1.45 Million

Previous $1.42 Million 14.11%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$172.58 - $196.48 $18,293 - $20,826	106 Added 1.3%	8,281 $1.62 Million
Q2 2024 Jul 08, 2024	BUY	$145.54 - $178.83 $145,103 - $178,293	997 Added 13.89%	8,175 $1.42 Million
Q1 2024 Apr 11, 2024	SELL	$165.67 - $199.94 $92,940 - $112,166	-561 Reduced 7.25%	7,178 $1.21 Million
Q4 2023 Jan 17, 2024	BUY	$151.44 - $200.09 $86,775 - $114,651	573 Added 8.0%	7,739 $1.53 Million
Q3 2023 Oct 16, 2023	SELL	$167.14 - $192.77 $49,640 - $57,252	-297 Reduced 3.98%	7,166 $1.25 Million
Q2 2023 Jul 19, 2023	BUY	$160.94 - $186.23 $154,502 - $178,780	960 Added 14.76%	7,463 $1.29 Million
Q1 2023 Apr 17, 2023	BUY	$145.48 - $175.02 $186,505 - $224,375	1,282 Added 24.55%	6,503 $1.08 Million
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $655 - $787	-5 Reduced 0.1%	5,221 $765,000
Q4 2022 Jan 17, 2023	SELL	$131.14 - $157.47 $463,579 - $556,656	-3,535 Reduced 40.35%	5,226 $766,000
Q3 2022 Oct 14, 2022	SELL	$148.29 - $182.55 $31,140 - $38,335	-210 Reduced 2.34%	8,761 $1.3 Million
Q2 2022 Jul 18, 2022	SELL	$155.97 - $200.09 $262,809 - $337,151	-1,685 Reduced 15.81%	8,971 $1.54 Million
Q1 2022 Apr 25, 2022	SELL	$181.39 - $234.03 $1.05 Million - $1.35 Million	-5,773 Reduced 35.14%	10,656 $2.01 Million
Q4 2021 Jan 25, 2022	SELL	$193.69 - $247.03 $928,356 - $1.18 Million	-4,793 Reduced 22.59%	16,429 $4.01 Million
Q3 2021 Oct 21, 2021	SELL	$189.29 - $209.69 $370,629 - $410,573	-1,958 Reduced 8.45%	21,222 $4.12 Million
Q2 2021 Jul 19, 2021	SELL	$155.9 - $187.99 $1.16 Million - $1.4 Million	-7,433 Reduced 24.28%	23,180 $4.32 Million
Q1 2021 Apr 19, 2021	SELL	$144.0 - $169.39 $270,288 - $317,945	-1,877 Reduced 5.78%	30,613 $4.82 Million
Q4 2020 Jan 14, 2021	SELL	$157.07 - $174.35 $11,309 - $12,553	-72 Reduced 0.22%	32,490 $5.38 Million
Q3 2020 Oct 19, 2020	SELL	$137.1 - $165.37 $148,616 - $179,261	-1,084 Reduced 3.22%	32,562 $5.39 Million
Q2 2020 Jul 28, 2020	BUY	$111.92 - $142.53 $1.93 Million - $2.46 Million	17,278 Added 105.56%	33,646 $4.61 Million
Q1 2020 Apr 20, 2020	BUY	$92.66 - $144.94 $37,805 - $59,135	408 Added 2.56%	16,368 $1.93 Million
Q4 2019 Jan 27, 2020	SELL	$116.25 - $133.25 $253,425 - $290,485	-2,180 Reduced 12.02%	15,960 $2.11 Million
Q3 2019 Oct 16, 2019	SELL	$112.57 - $128.43 $579,735 - $661,414	-5,150 Reduced 22.11%	18,140 $2.26 Million
Q2 2019 Jul 08, 2019	SELL	$97.98 - $114.28 $827,441 - $965,094	-8,445 Reduced 26.61%	23,290 $2.64 Million
Q1 2019 Apr 23, 2019	SELL	$81.56 - $100.67 $1.43 Million - $1.76 Million	-17,500 Reduced 35.54%	31,735 $3.2 Million
Q4 2018 Jan 17, 2019	SELL	$79.28 - $95.27 $1.86 Million - $2.24 Million	-23,510 Reduced 32.32%	49,235 $4.21 Million
Q3 2018 Oct 09, 2018	SELL	$83.5 - $93.23 $3.25 Million - $3.63 Million	-38,972 Reduced 34.88%	72,745 $6.66 Million
Q2 2018 Jul 23, 2018	SELL	$79.9 - $89.2 $14.7 Million - $16.5 Million	-184,418 Reduced 62.27%	111,717 $9.52 Million
Q1 2018 Apr 23, 2018	SELL	$71.51 - $84.69 $614,842 - $728,164	-8,598 Reduced 2.82%	296,135 $24.7 Million
Q4 2017 Jan 24, 2018	SELL	$63.24 - $72.8 $285,528 - $328,692	-4,515 Reduced 1.46%	304,733 $22 Million
Q3 2017 Oct 19, 2017	BUY	$59.73 - $65.4 $18.5 Million - $20.2 Million	309,248	309,248 $19.7 Million

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Account

Douglas Lane & Associates, LLC Zoetis Inc. Transaction History